Globenewswire

- Discovery efforts will focus on small molecules with differentiated clinical profiles to harness the broad potential of orexin agonism across different indications,
- First time Schrödinger is applying its computational platform in an orexin agonist setting enabled by Orexia’s structural biology capabilities.

New Solution Serves as the Intelligence Command Center for Life Sciences Commercial and Medical Teams.

New Engine Integrates All Sources of Insight and Uses Transparent AI to Overcome Barriers to Scale.

The Quantum Computing Company launches performance update, introduces new hybrid solvers, and broadens scope; now the only provider focused on delivering both annealing and gate-model quantum computers.

Industry veteran with decades of experience in company formation, scientific research, and drug development to join executive leadership team to accelerate pipeline potential.